Apellis Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.

About APLS

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. 

CEO
Cedric Francois
CEOCedric Francois
Employees
710
Employees710
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2009
Founded2009
Employees
710
Employees710

APLS Key Statistics

Market cap
2.20B
Market cap2.20B
Price-Earnings ratio
-10.97
Price-Earnings ratio-10.97
Dividend yield
—
Dividend yield—
Average volume
2.25M
Average volume2.25M
High today
$17.59
High today$17.59
Low today
$16.98
Low today$16.98
Open price
$17.35
Open price$17.35
Volume
2.87M
Volume2.87M
52 Week high
$50.98
52 Week high$50.98
52 Week low
$16.98
52 Week low$16.98

APLS News

TipRanks 5d
Apellis Pharmaceuticals Elects Craig Wheeler to Board

Apellis Pharmaceuticals ( (APLS) ) just unveiled an announcement. On April 17, 2025, Apellis Pharmaceuticals elected Craig A. Wheeler to its Board of Directors...

Analyst ratings

65%

of 23 ratings
Buy
65.2%
Hold
34.8%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.